… , we evaluated the preclinical effect of AS bcl-2 on chemotherapy for patients with gastric …
Thus, our preclinical evaluation of AS Bcl-2 suggests that, in targeting therapy through …

… for patients with other malignancies. Here, the authors review the current clinical and
preclinical evaluations of AS Bcl-2 and discuss its potential to act as a chemosensitizer and to …

… The mechanism of activity of these pharmacologic agents, termed chemosensitizers, … models
for the discovery and preclinical evaluation of new chemosensitizers, reviews those agents …

… We looked for all clinical or pre-clinical studies related … chemosensitizer depending on
MGMT status stay debated [40, 56–58]even if some phase II-III clinical trials recruits only patients …

… In this commentary/review, we focus on the relatively limited number of studies in the
literature where chloroquine has been tested in combination with chemotherapy or radiation in …

… Purpose: Our preclinical studies have shown that acidic and basic fibroblastic growth factors
confer broad spectrum chemoresistance and that low concentrations (10–50 μm) of suramin…

… Patients had to receive ESOM the two days before chemotherapy because preclinical studies
… , that is the minimal effective dose calculated on the basis of the preclinical studies [3, 4]. In …

… daily resulted in the greatest chemosensitization with a 3-fold … previously observed with
chemosensitization studies (22) … only 4 hours completely abolished chemosensitization. As ATM …

… The present study identified and validated a dosing nomogram and schedule to deliver low
and nontoxic suramin concentrations that produce chemosensitization in preclinical models. …

… Table 9.2 AbbVie data summarizing veliparib preclinical studies, monotherapy and …
produced by PARPi used as chemosensitiser in patients with advanced malignancies exposed to …